Brief: Armata Pharmaceuticals Announces Second Quarter Results And Provides General Corporate Update
12/08/2021 23:05
Aug 12 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS ANNOUNCES SECOND QUARTER RESULTS
AND
PROVIDES GENERAL CORPORATE UPDATE
* ARMATA PHARMACEUTICALS INC - TODD R. PATRICK, CEO, HAS
RETIRED
FROM THE COMPANY.
* ARMATA PHARMACEUTICALS INC - BRIAN VARNUM, PHD, FORMER
PRESIDENT
AND CHIEF DEVELOPMENT OFFICER, HAS BEEN APPOINTED THE COMPANY'S
NEW CEO
* ARMATA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.25
Source text for Eikon: ID:nPn9P4QTza
Further company coverage: ARMP.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles